Harmony Biosciences Holdings, Inc.HRMYNASDAQ
LOADING
|||
EPS Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
27.54%
↓ 84% below average
Average (26q)
169.94%
Historical baseline
Range
High:3613.51%
Low:-168.00%
Volatility
2225.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 27.54% |
| Q2 2025 | -13.75% |
| Q1 2025 | -8.05% |
| Q4 2024 | 7.41% |
| Q3 2024 | 305.00% |
| Q2 2024 | -70.59% |
| Q1 2024 | 47.83% |
| Q4 2023 | -28.13% |
| Q3 2023 | 12.28% |
| Q2 2023 | 16.33% |
| Q1 2023 | -40.24% |
| Q4 2022 | -44.59% |
| Q3 2022 | 270.00% |
| Q2 2022 | 11.11% |
| Q1 2022 | -7.69% |
| Q4 2021 | 329.41% |
| Q3 2021 | -168.00% |
| Q2 2021 | 92.31% |
| Q1 2021 | 3613.51% |
| Q4 2020 | 94.87% |
| Q3 2020 | 54.94% |
| Q2 2020 | 82.02% |
| Q1 2020 | -4.71% |
| Q4 2019 | -14.86% |
| Q3 2019 | -32.14% |
| Q2 2019 | 56.59% |
| Q1 2019 | 0.00% |